INTERNATIONAL PATENT: BLUESPHERE BIO, INC. FILES APPLICATION FOR "T CELL RECEPTORS TARGETING AN NPM1 NEOANTIGEN"

GENEVA, March 18 -- BLUESPHERE BIO, INC. (350 Technology Drive, Suite 520Pittsburgh, Pennsylvania 15219) filed a patent application (PCT/US2024/045132) for "T CELL RECEPTORS TARGETING AN NPM1 NEOANTIGEN" on Sep 04, 2024. With publication no. WO/2025/054164, the details related to the patent application was published on Mar 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BAHCECI, Erkut (c/o BlueSphere Bio, Inc.350 Technology Drive, Suite 520Pittsburgh, Pennsylvania 15219), BELLESIS, Andrew (c/o BlueSphere Bio, Inc.350 Technology Drive, Suite 520Pittsburgh, Pennsylvania 15219), CARTER, Alu...